Authors
Latest:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapeThis review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Latest:
Naloxone Training Requirements Vary Among StatesNew access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.
Latest:
Student Exchange Program Crafts Cultural Competency for PharmacistsAn advanced pharmacy practice experience program between a historically Black university and predominantly White institution impacted student perspectives on cultural competency.
Latest:
Pharma Moves Toward Value-Based ContractingPart 1 of this 4-part series provides a general overview of the trends that are moving payers and pharmaceutical companies in this direction.
Latest:
Key Strategies Released for Integrating Equity Into Health Technology AssessmentThe Center for Innovation & Value Research has released a final report recommending strategies to ensure health equity is integrated into health technology assessment, which can influence drug pricing and selection by payers, as well as patient access to drugs.
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Latest:
COVID-19 Booster Shots and the FutureKey opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Latest:
Health System-Based Specialty Pharmacy Offers Unique Advantages in HIV CareSpecialty pharmacists’ roles have grown in new and exciting ways in recent years, and those changes have directly impacted health outcomes for all specialty patients, including patients with HIV.
Latest:
The Role of a Clinical Pharmacist in Melanoma Care and EducationBecause of the likelihood that patients with melanoma will develop adverse effects on therapy, it is crucial for pharmacists to proactively educate patients and provide them with tools to help mitigate and manage these issues.
Latest:
Overview of Nurtec ODT for Prevention of Episodic MigraineNurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Latest:
The Role of Pharmacists in HIV Care Continues to ExpandPharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
Latest:
The Perfect Ingredient: Vaccine Education With Pharmacy Community Health WorkersIn Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.
Latest:
Providing Food Security From Across the Pharmacy CounterPharmacists can play a critical role in addressing food insecurity in their communities, with a variety of tools at their disposal.
Latest:
Lower Discontinuation Rates on Cycled Oral Antineoplastics Can Lead to Lower Medical Costs, Fewer HospitalizationsThese agents are likely to become the mainstay of cancer treatment in the very near future.
Latest:
CDC and FDA Recommendations for SARS-CoV-2 Booster ShotsExperts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
Latest:
Evaluation of Factors Driving Rheumatoid Arthritis Moderate to High Disease Activity on Routine Assessment of Patient Index Data 3 ScoreUtilization of the RAPID3 tool can be a beneficial way for pharmacists to complete disease activity assessments without physically seeing the patient in a clinic setting.
Latest:
Managing Blood Glucose Levels for Expectant Mothers With DiabetesCGM enhances diabetes management in pregnancy, improving outcomes.
Latest:
Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and MelanomaPharmacists play a vital role in therapy selection.
Latest:
Data Analytics Help Specialty Pharmacies Personalize Health CareAdvanced analytics will continue to make health care more accessible and empower pharmacists with the ability to personalize treatments.
Latest:
How I Overcame My Battle With Autoimmune Disease to Become a PharmacistAlthough it is critical that we listen to every patient we treat, it's also important to listen to the needs of our bodies first, as this will allow us to better care for others.
Latest:
FDA Grants Breakthrough Therapy Designation to SkinTE for Diabetic Foot UlcersSkinTE could aid Wagner grade 1 diabetic foot ulcers by regenerating and activating the tissues surrounding the wound to heal it completely.
Latest:
What is Needed to Turn the COVID-19 Pandemic into an EndemicFor COVID-19 to turn into an endemic, there are a few criteria that must be met.
Latest:
Clinical Overview: Oral Diabetes Medications in ChildrenDespite the surge in new diabetes cases, the treatment options in in children remain limited.
Latest:
Medically Integrated Pharmacies, Oral Oncolytic Agents Grow in Importance During COVID-19As practices have gained experience in the post-COVID-19 environment, health care professionals have found innovative ways to work around many of the obstacles the pandemic presents.
Latest:
Technology Can Help Ease Provider Burnout, Access to Health CareThe need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.
Latest:
With DSCSA Compliance Delay, Certain Requirements Still Require Action NowLaunching development of SOPs and communication with wholesalers is key.
Latest:
Managing Treatment With New and Expensive Drugs: What Pharmacy Leaders Need to KnowWith the introduction of expensive drugs and associated challenges for hospital budgets, pharmacy leaders benefit from strategically managing financial, clinical, and regulatory factors for sustainable care delivery.
Latest:
California Modifies End of Life Option ActAmendments reflecting more contemporary options could raise ethical questions for health care workers.
Latest:
New Therapy for Chronic Graft-Vs-Host Disease: AxatilimabAxatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.
